Last reviewed · How we verify

NCT04961489

Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes

Completed Last updated 14 July 2021
What this trial tests

trial in Surgery in 11,000 participants. Completed in 31 March 2021.

Timeline
1 August 2020
Primary endpoint
31 March 2021
31 March 2021

Quick facts

Lead sponsorNational Cancer Centre, Singapore
StatusCompleted
Study typeOBSERVATIONAL
Enrollment11,000
Start date1 August 2020
Primary completion31 March 2021
Estimated completion31 March 2021
Sites2 locations across Singapore

Conditions studied

Sponsor

National Cancer Centre, Singapore

Who can join

Adults 21 to 100, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to look at the impact on patient outcomes arising from measures implemented during the COVID-19 pandemic. The information and knowledge from this study will be useful for the management and allocation of hospital resources and patients in tne event of a disease outbreak.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other National Cancer Centre, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing